- Home
- MESO vs GT Comparison
MESO vs GT Comparison
Compare MESO & GT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MESO | GT |
|---|---|---|
| Founded | 2004 | 1898 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Automotive Aftermarket |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MESO | GT |
|---|---|---|
| Price | $18.65 | $9.07 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | ★ $24.00 | $10.36 |
| AVG Volume (30 Days) | 218.4K | ★ 5.3M |
| Earning Date | 02-25-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $17,198,000.00 | ★ $18,310,000,000.00 |
| Revenue This Year | $576.59 | N/A |
| Revenue Next Year | $41.15 | $0.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 191.39 | N/A |
| 52 Week Low | $9.61 | $6.51 |
| 52 Week High | $21.00 | $12.03 |
Technical Indicators
Market Signals| Indicator | MESO | GT |
|---|---|---|
| Relative Strength Index (RSI) | 56.49 | 58.80 |
| Support Level | $17.90 | $8.67 |
| Resistance Level | $18.73 | $9.01 |
| Average True Range (ATR) | 0.51 | 0.25 |
| MACD | -0.14 | -0.01 |
| Stochastic Oscillator | 43.00 | 62.16 |
Price Performance
Historical ComparisonAbout MESO Mesoblast Limited
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.
About GT The Goodyear Tire & Rubber Company
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific.